• Profile
Close

Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer

European Archives of Oto-Rhino-Laryngology Jan 10, 2018

Mao Y, et al. - The goal of this paper was to detect the high-risk patients according to a preoperatively determined signature of the platelet-to-lymphocyte ratio (PLR) of > 193.55, as an indicator of poor treatment outcome in laryngeal squamous cell carcinoma (LSCC) patients. As per findings, poor outcomes were experienced by patients with PLR > 193.55. These patients represented malnutrition and more advanced cancer stage.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay